Navigation Links
Carto XP Electroanatomical Mapping System

ProductsCarto XP Electroanatomical Mapping System
Company Biosense Webster, a Johnson & Johnson Company
Item Carto XP Electroanatomical Mapping System
Features Increased location accuracy
  • Visualize catheter tip location with sensor accuracies of less than 1 mm.
  • Navigate with six degrees of freedom--X, Y, Z, pitch, roll, and yaw.
  • Precisely re-navigate to areas of interest using the system's location memory.

    • Increased site-targeting efficiency
  • Quickly diagnose clinical conditions based on easy-to-read 3-D electroanatomical maps.
  • Visualize electrogram data, which is color coded and superimposed on anatomical maps.
  • Display true anatomic variations for individual patients.

    • Increased treatment safety
  • Tag critical structures to prevent AV block during ablation.
  • Visually assess ablation line of block and gap.
  • Visualize catheter icon to verify stability.
  • Tag ablation sites to improve safety by reducing duplicate applications to the same area.
  • Increase margin of safety during ablation with temperature sensing catheter.
    • Description The CARTO XP Electroanatomical Mapping System combines the legendary accuracy of the CARTO System with the operating ease of Windows* software. It integrates seamlessly into your EP environment, adding powerful new tools that enhance your clinical capabilities in an easy-to-upgrade platform that takes you into the future of EP. The intended use of the CARTO XP System is catheter-based cardiac electrophysiological (EP) mapping. The CARTO XP System provides important information on the electrical activity of the heart, in a procedure that uses the same techniques and tools as other cardiac catheter mapping systems. You can use the CARTO XP System on patients who are eligible for a conventional electrophysiological study.
    Info Biosense Webster, a Johnson & Johnson Company
    Customer Service: (800) 729-9010
    Web site: http://www.biosensewebster.com/

    Related medicine products :

    1. Shandon Paraffin Block Cartons
    2. Luma-Cath Lumen Diagnostic Mapping Catheters Fixed and Steerable Curves
    3. Webster Lasso Circular Mapping Catheter
    4. Cortical Mapping Unit
    5. Silicone Oil Cannula System - 20 Gauge
    6. Silicone Oil Cannula System - 19 Gauge
    7. SuperVu Galilean System
    8. KOWA nonmyd 7 / VK-2 Digital Imaging System
    9. KOWA nonmyd a-D / VK-2 Digital Imaging System
    10. Refraction System RT-2100
    11. Odyssey Phacoemulsification System
    ...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
    ...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
    ...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
    ...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
    Medicine Products:
    (Date:7/3/2009)...searchers express hope that finding will lead to t...y News) -- U.S. researchers say they,ve found a m... of relapsed lung cancer. , When caught early, ...re not detected until the disease is well advanced... remission, the disease often springs back more vi...
    (Date:7/3/2009)..., WASHINGTON, July 3 Re...ing for language in health care reform legislation...es. If this happens, many women could lose coverag...ce currently includes. Plus, millions of uninsured... despite having been promised a better quality of ...
    (Date:7/3/2009)... Eva,s Village, ( http://ww...-Poverty Charity, Seeks Buyers for 35mm Michael Ja...eo. , Paterson, NJ (PRWEB...illage.org ), a non-profit New Jersey anti-poverty...c 35mm film print of Michael Jackson,s "Thril...
    (Date:7/3/2009)... Two companies and three in...excellence at an annual international competition ...mpions. The 15,000-member SafetyXChange.org commu...s on June 30, 2009 at http://www.safetyxchange.or...le and organizations who dedicate their lives to k...
    Breaking Medicine News(10 mins):Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4
    ...ave been coming to Spain's sun-kissed eastern and ...mong them are connoisseurs of the climate's restor...gresses, more and more health "tourists" and forei... retirement by the sea have been making increasing...
    ...ld have a beneficial effect on the immune system, ...e vegetable is considered to be rich in vitamin C,... like iron, calcium, manganese, magnesium and phos...n known that potatoes are good for bowel health. ...
    ... Norwegians flock to the coastal Spanish town of A...ion centre for problems ranging from rheumatism to...l year and it rains often. You can understand why ...he tanned head of the centre, Torild Thorvaldsen, ...
    ...to trade shows are an indicator of an industry's h... the world's biggest wine and spirits fair, confir...anisers estimate more than 50,000 people attended ...-yearly event in Bordeaux, a three percent rise on...
    Other Medicine News:Health News:Health Tourists Put Spanish Service Under Strain 2Health News:Intake of Potatoes Boosts the Immune System 2Health News:Norwegians Take in the Sun in Spain on Doctors' Orders 2Health News:World Wine Sales Brisk, but French Producers Hungover 2Health News:World Wine Sales Brisk, but French Producers Hungover 3
    (Date:6/29/2009)...e Study Seeks to Assess RSV Burden in Outpatient S...itment to Pediatric Research , , GAITHERSBURG... to advance its commitment to pediatric research w...l prospective study designed to assess the burden ... infants 32-to-35 weeks gestational age (GA) in ou...
    (Date:6/29/2009)...a Targets for Novel Biotherapeutics Based On Natur...June 29 Pangu BioPharma, a subsidi...he filing of its third patent application on propr...ynthetases. Although tRNA synthetases are univers...achinery found in all organisms, human synthetases...
    (Date:6/28/2009)...EDE DO CORONADO, Portugal, June 29 ...that add-on treatment with the novel,once-daily ...e; ESL) resulted,in a marked and sustained decrea..., Results from the one-year extension of a piv... presented at the International Congress for Epile...
    (Date:6/26/2009)...R, N.J., June 26 Sanof...t been made aware of data associated with a retros...results of these data clearly show that no definit...causal relationship between Lantus(R) (insulin gla...malignancies, as the authors of the study point ou...
    Breaking Medicine Technology:MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3EntreMed to Present at BioPartnering Europe Conference 8196 1EntreMed to Present at BioPartnering Europe Conference 8196 2EntreMed to Present at BioPartnering Europe Conference 8196 3Take advantage of reduced pre registration rates for the IOF World Congress on Osteoporosis 5317 1Synaptics to Report First Quarter Results on October 23 5316 1Synaptics to Report First Quarter Results on October 23 5316 2Smithsonian perspective 3A Biodiversity in a warmer world 5313 1Smithsonian perspective 3A Biodiversity in a warmer world 5313 2
    ...products from Pharmion,s pipeline provide support ...g promising Phase III,data on use of Thalidomide t...2007 /PRNewswire-FirstCall/ -- Pharmion,Corporatio...udies,investigating the company,s marketed and pip...he American Society of Clinical,Oncology,s (ASCO) ...
    ...ne 01, 2007 /PRNewswire-FirstCall/ - Research,coll...s") are,scheduled to deliver a poster presentation...merican Society of Clinical Oncology,(ASCO) Annual...e,data cover final results of Oncolytics, U.K. Pha...entitled "Final Results of a Phase I Study of,Wild...
    Other Medicine Technology:Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 2Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 3Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 4Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 5Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 6Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 7Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2